Our Hair Relaxer Litigation Team monitors Georgia cases as they survive motions to dismiss. The team also discusses the status of pending cases in the MDL and Illinois state courts. Our firm continues advancing chemical hair relaxer litigation in state and federal courts.
Legal action began following the October 17, 2022, publication of a study from the National Institutes of Health, which found that women who often use hair relaxer products are more than twice as likely to develop uterine cancer as those who don’t.
During the last few months, more cases have been filed in Illinois state courts, where several defendant corporations are. The influx of cases has led them to be combined for pre-trial and discovery matters. Initial discovery efforts are ongoing. Then, these cases will be reassigned to trial judges in their original venues.
Plaintiffs in Georgia state courts successfully challenged the defendants’ initial motions to dismiss. A stay of discovery has been put in place while these rulings are under appeal. Hearing on motions to dismiss in other cases are scheduled over the next few weeks.
Beasley Allen has been heavily involved in federal court multidistrict litigation (MDL) as part of the plaintiffs’ expert committee and otherwise helping to advance the Plantiffs’ Steering Committee’s positions. Initial discovery requests were sent to the primary six defendants identified in the MDL during the last week of June.
Additional defendants have started to make appearances in the case, and more are expected as litigation progresses.
This case is being pursued by a team of Beasley Allen lawyers.
Our firm is actively investigating cases of women who developed uterine cancer, endometrial cancer, and ovarian cancer after using chemical hair relaxers. Contact Beasley Allen for a free case evaluation.